![](/img/cover-not-exists.png)
180 Hematologic responses to flexible dosing of azacitidine in higher risk MDS/AML: 7 day therapy over an 8 day period
R. Kumar, P. Skrabek, K. Paulson, M.D. Seftel, D.S. Houston, D. Szwajcer, P. Burns, B. Lozar, V. Bourrier, S. NavaratnamVolume:
35
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/s0145-2126(11)70182-5
File:
PDF, 224 KB
english, 2011